Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. News/
    3. Innovation/
    4. Innovation-opedia: What is a mosaic vaccine?
    Graphic featuring a syringe to illustrate an HIV vaccine trial
    Innovation

    Innovation-opedia: What is a mosaic vaccine?

    As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

    Written by Johnson & Johnson
     | July 22, 2019
    July 22, 2019
    Illustrated handwritten definition of a mosaic HIV vaccine
    Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
    Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
    Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
    Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

    We’re committed to helping lead the fight against HIV/AIDS

    Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
    Learn more
    CTA-Red ribbon HIV

    HIV vaccine J&J Innovative Medicine Johnson & Johnson

    More from Johnson & Johnson

    Health & wellness
    January 13, 2026

    What is a rheumatic disease?

    More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.
    Read more
    Innovation
    January 12, 2026

    Using your own cells to fight cancer

    Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.
    Read more
    Innovation
    January 9, 2026

    What are biologics?

    Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.
    Read more